Epilepsy and Diffuse interstitial lung disease

Summary:

Diffuse interstitial lung disease is found among people with Epilepsy, especially for people who are female, 40-49 old.

The study analyzes which people have Diffuse interstitial lung disease with Epilepsy. It is created by eHealthMe based on reports of 26 people who have Epilepsy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,163 drugs and 1,776 conditions by eHealthMe. Check the latest studies of Epilepsy.

What is Diffuse interstitial lung disease?

Diffuse interstitial lung disease (group of lung diseases affecting the interstitium) is found to be associated with 232 drugs and 801 conditions by eHealthMe. Check the latest studies of Diffuse interstitial lung disease.



On Jul, 14, 2026

26 people who have Epilepsy and Diffuse Interstitial Lung Disease are studied.

Would you have Diffuse interstitial lung disease when you have Epilepsy?

Gender of people who have Epilepsy and experienced Diffuse Interstitial Lung Disease *:

  • female: 92.31 %
  • male: 7.69 %

Age of people who have Epilepsy and experienced Diffuse Interstitial Lung Disease *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 7.69 %
  • 30-39: 0.0 %
  • 40-49: 76.92 %
  • 50-59: 3.85 %
  • 60+: 11.54 %

Common co-existing conditions for these people *:

  1. Pneumonia: 19 people, 73.08%
  2. Asthma: 19 people, 73.08%
  3. Metastases To Central Nervous System (cancer spreads to central nervous system): 19 people, 73.08%
  4. Malignant Melanoma (skin cancer rises from melancytes): 19 people, 73.08%
  5. Constipation: 13 people, 50.00%
  6. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.85%
  7. Fever: 1 person, 3.85%
  8. Cough: 1 person, 3.85%
  9. Dyspnea (difficult or laboured breathing): 1 person, 3.85%
  10. Embolism Venous (embolus may pass into the arterial system): 1 person, 3.85%

Common drugs taken by these people *:

  1. Symbicort: 19 people, 73.08%
  2. Heparin: 14 people, 53.85%
  3. Lamictal: 3 people, 11.54%
  4. Primidone: 2 people, 7.69%
  5. Xarelto: 1 person, 3.85%
  6. Lamotrigine: 1 person, 3.85%
  7. Albuterol: 1 person, 3.85%
  8. Atrovent: 1 person, 3.85%
  9. Bisacodyl: 1 person, 3.85%
  10. Clozaril: 1 person, 3.85%

Common symptoms for these people *:

  1. Fever: 21 people, 80.77%
  2. Cough: 20 people, 76.92%
  3. Nausea (feeling of having an urge to vomit): 20 people, 76.92%
  4. Oedema Peripheral (superficial swelling): 20 people, 76.92%
  5. General Physical Health Deterioration (weak health status): 20 people, 76.92%
  6. Nausea And Vomiting: 20 people, 76.92%
  7. Chills (felling of cold): 19 people, 73.08%
  8. Colitis (inflammation of colon): 19 people, 73.08%
  9. Agitation (state of anxiety or nervous excitement): 19 people, 73.08%
  10. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 19 people, 73.08%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Diffuse interstitial lung disease?

- Check whether Diffuse interstitial lung disease is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Diffuse interstitial lung disease:

All the conditions that are associated with Diffuse interstitial lung disease:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Diffuse interstitial lung disease and Epilepsy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: